Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs

Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs

Objective(s): Gallium-68 DOTA-DPhe1-Tyr3-Octreotide (68Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging, rese...

Full description

Bibliographic Details
Main Authors:	mojdeh naderi, samaneh zolghadri, hassan yousefnia, ali ramazani, amir reza jalilian
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2016-01-01
Series:	Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:	Ga-68 Octreotide Internal Dosimetry Somatostatin
Online Access:	http://aojnmb.mums.ac.ir/pdf_5043_76a2ad14878b96963330ff68c4e18f99.html

Similar Items

Absorbed Dose of Human Organs after Injection of 68Ga-EDTMP: Estimation from Biodistribution Data in Wild-Type Rats
by: Hassan Yousefnia, et al.
Published: (2018-12-01)

Evaluation of the Possible Utilization of 68Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer
by: Hassan Yousefnia, et al.
Published: (2018-01-01)

Semiquantitative Analysis of Physiological Biodistribution of <sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-DOTANOC
by: Evrim SÜRER BUDAK, et al.
Published: (2023-07-01)

Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
by: Lennert Boeckxstaens, et al.
Published: (2023-06-01)

Preliminary Dosimetry Study of 67Ga-AATS for Human Based on Biodistribution Data in Rats
by: Hassan Yousefnia, et al.
Published: (2015-07-01)

Preparation and Quality Control of 68Ga-Citrate for PET Applications
by: Ayuob Aghanejad, et al.
Published: (2015-07-01)

Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
by: Schreiter Nils Friedemann, et al.
Published: (2014-12-01)

Characterization of 68Ge/68Ga Generator and Quality Control of its Eluate
by: S Zolghadri, et al.
Published: (2018-08-01)

Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
by: Martin H. Cherk, et al.
Published: (2018-01-01)

68Ga-DOTA-DiPSMA PET/CT Imaging: Biodistribution, Dosimetry, and Preliminary Application in Prostate Cancer
by: Jiaying Zhang, et al.
Published: (2022-01-01)

Octreotide: un potente analgesico non-narcotico per instillazione oculare - Octreotide: a powerful non-narcotic analgesic for ocular instillation
by: Nicola Maratea
Published: (2015-06-01)

Octreotide: a powerful non-narcotic analgesic for ocular instillation
by: Nicola Maratea
Published: (2015-05-01)

68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients
by: Virginia Liberini, et al.
Published: (2021-01-01)

Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01)

Pindborg Tumor—An Uncommon Odontogenic Tumor Detected by 68Ga-DOTATOC
by: Anna Herden, et al.
Published: (2022-02-01)

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11
by: Nicole N. Waterhouse, et al.
Published: (2020-02-01)

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report
by: Ringo Manta, et al.
Published: (2022-04-01)

A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
by: Rosalba Mansi, et al.
Published: (2020-08-01)

Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as a bone pain palliation agent
by: samaneh zolghadri, et al.
Published: (2015-01-01)

Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as a bone pain palliation agent
by: samaneh zolghadri, et al.
Published: (2015-01-01)

Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
by: Vusani Mandiwana, et al.
Published: (2021-04-01)

Preoperative detection of functional somatostatin receptors in a patient with an insulinoma
by: Kohei Oguni, et al.
Published: (2023-08-01)

Unresectable Recurrent Multiple Meningioma: A Case Report with Radiological Response to Somatostatin Analogues
by: Ana Ortolá Buigues, et al.
Published: (2016-08-01)

Role of Somatostatin Signalling in Neuroendocrine Tumours
by: Olesja Rogoza, et al.
Published: (2022-01-01)

Meningiomas and Somatostatin Analogs: A Systematic Scoping Review on Current Insights and Future Perspectives
by: Sofie Eline Tollefsen, et al.
Published: (2023-03-01)

Imaging Characteristics of 68Ga-DOTATATE PET/CT in Tumor-Induced Osteomalacia
by: ZHANG Yuwei, et al.
Published: (2023-07-01)

The Current Development Status of 68Ge-68Ga Generators for Medical Use
by: LI Long;ZHOU Sai;DING Songdong;HUANG Yong
Published: (2023-02-01)

Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review
by: Francesco Lancellotti, et al.
Published: (2019-07-01)

68Ga-Based Radiopharmaceuticals: Production and Application Relationship
by: Irina Velikyan
Published: (2015-07-01)

¿Son útiles la somatostatina y sus análogos (octreótido y lanreótido) en el manejo del paciente con fístula entero-cutánea?: Revisión sistemática de la literatura
by: Luis Carlos Domínguez, et al.

A case of malignant insulinoma responsive to somatostatin analogs treatment
by: Mariasmeralda Caliri, et al.
Published: (2018-12-01)

[<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4, a PET Radiotracer in the Diagnosis of SST<sub>2</sub>R-Positive Tumors: Preclinical and First Clinical Results
by: Panagiotis Kanellopoulos, et al.
Published: (2022-11-01)

Paget’s Disease Mimicking Bone Metastasis in a Patient with Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT
by: Naciye Sinem Gezer, et al.
Published: (2016-07-01)

Relevance of Volumetric Parameters Applied to [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
by: Luca Urso, et al.
Published: (2023-02-01)

Good practices for 68Ga radiopharmaceutical production
by: Bryce J. B. Nelson, et al.
Published: (2022-10-01)

Occupational radiation exposure assessment during the management of [68Ga]Ga-DOTA-TOC
by: Mercedes Riveira-Martin, et al.
Published: (2022-10-01)

Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review
by: Giulia Poletto, et al.
Published: (2022-11-01)

Adherence to somatostatin analog therapy for acromegaly
by: I. A. Ilovayskaya
Published: (2021-05-01)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
by: Sang Ouk Chin, et al.
Published: (2019-03-01)

A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
by: Keiko Yamaoka, et al.
Published: (2021-05-01)